[Proposal of HIV, HBV and HCV targeted screening: short period feasibility study in a free-access outpatient medical structure]. [Article in French]

[Proposal of HIV, HBV and HCV targeted screening: short period feasibility study in a free-access outpatient medical structure]. [Article in French]

Aparicio C1Mourez TSimoneau GMagnier JDGalichon BPlaisance PBergmann JFSellier PPresse Med. 2012 Oct;41(10):e517-23.

Author information: Hôpital Lariboisière, urgences accueil et traitement des urgences, 75010 Paris, France.

Abstract : OBJECTIVES: In France, patients coming from sub-Saharan Africa, French Indies and French Guiana are frequently missed HIV, HBV and HCV diagnosis, despite high prevalence of these infections. METHODS: Targeted proposal of HIV, HBV and HCV screening, using sensitive enzyme immunoassays, to any adult patient originating of the above mentioned areas, with/without medical insurance, consulting for a medical issue in outpatients’ department. Monocentric prospective study in a hospital in Paris during 28 consecutive days in 2010. RESULTS: Among the 272 eligible patients, 166 were tested (patients’ acceptance: 61%). 180/272 (66%) alleged being tested previously for HIV, women (66/87, 76%) more frequently than men (114/185, 62%), P=0.02. Patients’ acceptance seemed higher in patients mentioning no previous test than in patients reporting previous test. Among the patients who refused being tested, reporting a previous negative HIV test, more than a quarter has been tested more than 1 year ago. Among the 166 tested patients, 120 (72%) came back to get their results, men (89/113, 79%) more frequently than women (31/53, 58.5%), P=0.009; recently metropolitan patients more frequently than longer metropolitan patients, P=0.01; patients without any job more frequently than patients with a job, P=0.01. Three (1.8%) HIV tests returned positive; HBsAg was positive in 13 (7.8%) patients; 54 patients (32.7%) had a negative hepatitis B screening (anti-HBcAb+HBsAg+anti-HBsAb), attesting to sensitivity to this infection, only 18 patients (10.9%) showed isolated anti-HBsAb at protective levels. Eighty-one patients (49.1%) exhibited anti-HBcAb, confirming the high prevalence of HBV infection in the areas the patients came from. Six patients (3.6%) had anti-HCVAb. There was no co-infection. CONCLUSION: Targeted HIV, HBV and HCV screening to patients coming from high prevalence areas in outpatients’ department appears a very cost-effective strategy.